Please login to the form below
New Accounts, May, 2008 - Advertising
New pharmaceutical account wins notified to us by the winning agency for the period February, 2008 to April, 2008 inclusive
New pharmaceutical account wins notified to us by the winning agency for the period February, 2008 to April, 2008 inclusive
| CLIENT | PRODUCT | THERAPEUTIC AREA | WINNING AGENCY |
| Abbott UK | Humira | Rheumatoid arthritis | Woolley Pau |
| Baxter Healthcare UK | Brevibloc | Cardiology | WBR |
| Baxter Healthcare UK | Suprane | Anaesthesiology | WBR |
| Sanofi Pasteur MSD | Travel vaccines portfolio | Vaccine | Woolley Pau |
| Wyeth | Prostap | Urology | Oak |
Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may not be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email new_accounts@pmlive.com
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Senior Health Psychologist, London
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
- Scientists discover new approach to treat brain tumours
- AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
- Takeda and Daiichi Sankyo collaborate to create wearable device
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- Sanofi and Regeneron receive FDA approval for eosinophilic oesophagitis treatment
- UICC launches global ATOM Coalition to increase access to essential cancer medicines
- Improving Drug Access with Data Analytics
- How digital health is changing the relationship between patients and health providers | OPEN Health
- NICE recommends Sanofi and Regeneron’s Libtayo for advanced CSCC
- Roche’s Polivy receives EC approval for lymphoma therapy
- Eli Lilly announces $2.1bn investment in new manufacturing sites
- How ‘Greenwashing’ accusations could delay the very changes its supporters demand
PMHub
Bedrock Healthcare Communications
Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...
Latest intelligence
- How ‘Greenwashing’ accusations could delay the very changes its supporters demand
- Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
- What does the future hold for clinical trial recruitment?
- The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
- When is an agency not an agency?
- The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
